The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
COHERUS BIOSCIENCES INC COM 19249H103 17,863 618,106 SH   SOLE   618,106 0 0
COLLEGIUM PHARMACEUTICAL INC COM 19459J104 3,157 176,976 SH   SOLE   176,976 0 0
ENERGY FUELS INC COM NEW 292671708 5,065 1,138,170 SH   SOLE   1,138,170 0 0
SABRE CORP COM 78573M104 22,495 945,157 SH   SOLE   945,157 0 0
VERACYTE INC COM 92337F107 3,915 351,435 SH   SOLE   351,435 0 0
XBIOTECH INC COM 98400H102 1,912 105,770 SH   SOLE   105,770 0 0